Literature DB >> 16149796

Efficient solid-phase-based total synthesis of the bisintercalator TANDEM.

John P Malkinson1, Michael K Anim, Mire Zloh, Mark Searcey, Andrew J Hampshire, Keith R Fox.   

Abstract

[reaction: see text] In this article, the first solid-phase-based total synthesis of TANDEM, a synthetic analogue of triostin A, is described. In initial studies, the synthesis incorporated depsipeptide formation, introduction of chromophores, and disulfide bond formation on the solid phase, prior to a final solution-phase macrolactamization, to give the target molecule. Although pure TANDEM was obtained in an overall yield comparable to those for all syntheses to date, the yield of the final cyclization was low (11%). A more efficient approach involved removal from the solid phase prior to disulfide bond formation. The resulting linear peptide underwent macrolactamization under mild conditions and high dilution. Final disulfide bond formation was essentially quantitative and gave the target molecule, TANDEM, in an overall yield of 18%. The final compound was assessed for its ability to bind to 5'-TpA sequences on DNA by DNase I footprinting. This efficient synthesis sets the stage for a study of the structure-activity relationship of TANDEM and the natural product triostin A, with analogues containing "point mutations" at every site within the cyclic compounds.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16149796     DOI: 10.1021/jo050959a

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  One-Bead-Two-Compound Thioether Bridged Macrocyclic γ-AApeptide Screening Library against EphA2.

Authors:  Yan Shi; Sridevi Challa; Peng Sang; Fengyu She; Chunpu Li; Geoffrey M Gray; Alekhya Nimmagadda; Peng Teng; Timothy Odom; Yan Wang; Arjan van der Vaart; Qi Li; Jianfeng Cai
Journal:  J Med Chem       Date:  2017-11-14       Impact factor: 7.446

2.  Rationally engineered total biosynthesis of a synthetic analogue of a natural quinomycin depsipeptide in Escherichia coli.

Authors:  Kenji Watanabe; Kinya Hotta; Alex P Praseuth; Mark Searcey; Clay C C Wang; Hiroki Oguri; Hideaki Oikawa
Journal:  Chembiochem       Date:  2009-08-17       Impact factor: 3.164

Review 3.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.